Man Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-119,740
| Closed | -$103K | – | 2180 |
|
|
2023
Q4 | $103K | Buy |
+119,740
| New | +$103K | ﹤0.01% | 1856 |
|
|
2023
Q3 | – | Sell |
-95,785
| Closed | -$248K | – | 1755 |
|
|
2023
Q2 | $248K | Buy |
+95,785
| New | +$248K | ﹤0.01% | 1733 |
|
|
2023
Q1 | – | Sell |
-137,544
| Closed | -$690K | – | 1469 |
|
|
2022
Q4 | $690K | Buy |
137,544
+101,044
| +277% | +$507K | ﹤0.01% | 1420 |
|
|
2022
Q3 | $477K | Buy |
+36,500
| New | +$477K | ﹤0.01% | 1500 |
|
|
2022
Q2 | – | Sell |
-21,800
| Closed | -$332K | – | 1535 |
|
|
2022
Q1 | $332K | Buy |
21,800
+7,100
| +48% | +$108K | ﹤0.01% | 1680 |
|
|
2021
Q4 | $260K | Buy |
14,700
+1,100
| +8% | +$19.5K | ﹤0.01% | 1700 |
|
|
2021
Q3 | $286K | Buy |
+13,600
| New | +$286K | ﹤0.01% | 1643 |
|